Recombinant allergens promote expression of CD203c on basophils in sensitized individuals

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 1, 2002, Pages 102-109

  Hauswirth, Alexander W ^a   Natter, Susanne ^b   Ghannadan, Minoo ^a   Majlesi, Yasamin ^a   Schernthaner, Gerit Holger ^a,b   Sperr, Wolfgang R ^a   Bühring, Hans Jörg ^c   Valenta, Rudolf ^b   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Allergy; Basophils; CD203c; Diagnostic test; E NPP3; Recombinant allergens

Indexed keywords

ALLERGEN; ALLOANTIGEN; CD203C ANTIGEN; CD63 ANTIGEN; IMMUNOGLOBULIN E RECEPTOR; ISOENZYME; POLLEN ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLERGY TEST; ANTIGEN EXPRESSION; ARTICLE; BASOPHIL; BIRCH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIZATION; TIME;

EID: 0036968257     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.125257     Document Type: Article

References (33)

1. Kay AB. Allergy and allergic diseases. Oxford, United Kingdom: Blackwell Science; 1997.
2. Dattwyler R, Kaplan AP, Austen KF. Human anaphylaxis. In: Kaplan AP, editor. Allergy. 1st ed. New York: Churchville Livingston; 1985. p. 599-607.
3. Valenta R, Kraft D. Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995;7:751-6.
4. Valenta R, Vrtala S, Laffer S, Spitzauer S, Kraft D. Recombinant allergens. Allergy 1998;53:552-61.
5. Valenta R, Kraft D. Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev 2001;179:119-27.
6. Valenta R, Sperr WR, Ferreira F, Valent P, Sillaber C, Tejkl M, et. al. Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens. J Allergy Clin Immunol 1993;91:88-97.
7. Ball T, Vrtala S, Sperr WR, Valent P, Susani M, Kraft D, et al. Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction. J Biol Chem 1994;269:28323-8.
8. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896-904.
9. Bousquet J, Lebel B, Dhivert H, Bataille Y, Martinot B, Michel FB. Nasal challenge with pollen grains, skin prick tests, and specific IgE in patients with grass pollen allergy. Clin Allergy 1987;17:529-36.
10. Pelikan Z. The diagnostic approach to immediate type hypersensitivity in patients with allergic rhinitis; a comparison of nasal challenges and serum RAST. Ann Allergy 1983;51:395-400.
11. Rasaneh L, Kuusisto P, Penttila M, Nieminen M, Savolainen J, Lehto M. Comparison of immunologic tests in the diagnosis of occupational asthma and rhinitis. Allergy 1994;49:342-7.
12. Niederberger V, Stübner P, Spitzauer S, Kraft D, Valenta R, Ehrenberger K, et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study peformed with recombinant allergen molecules. J Invest Dermatol 2001;117:848-51.
13. Vrtala S, Sperr WR, Reimitzer I, Ree R, Laffer S, Müller W-D, et al. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl p V allergen. J Immunol 1993;151:4773-81.
14. Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, et al. Immunologic characterization of purified recombinant grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5). J Allergy Clin Immunol 1996;97:781-7.
15. Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991;88:328-38.
16. Gane P, Pequet C, Crespeau H, Lambin P, Leynadier F, Rouger P. Flow cytometric monitoring of allergen induced basophil activation. Cytometry 1995;19:361-5.
17. Sainte-Laudy J, Sabbah A, Vallon C, Guerin JC. Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry. Comparison with histamine release. Inflamm Res 1998;47:401-8.
18. Pâris-Köhler A, Demoly P, Persi L, Lebel B, Bousquet J, Arnoux B. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 2000;105:339-45.
19. Bühring H-J, Simmons PJ, Pudney M, Muller R, Jarrossay D, Agthoven A, et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multi- and unipotent progenitors. Blood 1999;94:2343-56.
20. Bühring HJ, Seiffert M, Giesert C, Marxer A, Valent P, Kanz L, et al. The basophil activation marker defined by antibody 97A6 is identical with ecto-nucleotide pyrophosphatase/phosphodiesterase 3 (E-NPP3: CD203c). Blood 2001;97:3303-5.
21. Platz I, Binder M, Marxer A, Lischka G, Valent P, Bühring HJ. Hymenoptera venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 (E-NPP3, CD203c) in sensitized individuals. Int Arch Allergy Immunol 2001;126:335-42.
22. Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Scheiner O, et al. The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935-8.
23. Susani M, Jertschin P, Dolecek C, Sperr WR, Valent P, Ebner C, et al. High level expression of birch pollen profilin (Bet v 2) in Escherichia coli: purification and characterization of the recombinant allergen. Biochem Biophys Res Commun 1995;215:250-63.
24. Heiss S, Mahler V, Steiner R, Spitzauer S, Schweiger C, Kraft D, et al. Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing. J Invest Dermatol 1999;113:830-7.
25. Cirillo R, Triggiani M, Siri L, Cicarelli A, Pettit GR, Condorelli M, et al. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol 1990;144:3891-7.
26. Sperr WR, Agis H, Semper H, Valenta R, Susani M, Sperr M, et al. Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. Int Arch Allergy Immunol 1997;114:68-73.
27. Valent P, Besemer J, Muhm M, Majdic O, Lechner K, Bettelheim P. Interleukin-3 activates human blood basophils via high affinity binding sites. Proc Natl Acad Sci 1989;86:5542-6.
28. Modderman PW. Cluster report CD63. In: Knapp W, et al, editors. Leukocyte typing IV. Oxford, United Kingdom: Oxford University Press; 1989. p. 1042
29. Bochner BS. Systemic activation of basophils and eosinophils: markers and consequences. J Allergy Clin Immunol 2000;106:292-302.
30. Sihra B, Kon O, Grant J, Kay A. Expression of high-affinity IgE receptors (FcεRI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol 1997;99:699-706.
31. Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin MH, Kilgus O. et al. Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med 1994;179:745-50.
32. Katho N, Kraft S, Wessendorf JHM, Bieber T. The high-affinity IgE receptor (FcεRI) blocks apoptosis in normal human monocytes. J Clin Invest 2000;105:183-90.
33. Sobotka AK, Dembo M, Goldstein B, Lichtenstein LM. Antigen-specific desensitization of human basophils. J Immunol 1979;122:511-7.